Global Monopoly of Technology

On the second exhibition day of the Côte d'Azur Technology Expo, the local tyrants from the Middle East led a delegation to see the goods today, and their arrival also attracted a lot of media attention and reports.

When the local tyrants come, they are naturally treated as guests by the sales department on the Cote d'Azur.

In the eyes of many people, these people wearing white robes and turbans are all "banknotes" that can walk automatically. These "banknotes" are now automatically going to Luo Sheng's pocket.

Seeing this group of people enter the City of Galaxy, almost all of them are surprisingly unanimous in their envy of the Riviera. This is the rhythm of big business.

Sure enough, the local tyrants just arrived in the morning, and the exact news came out in the afternoon. The business groups sent by many Middle Eastern countries signed a large contract with Cote d'Azur.

The company will provide these customers in the Middle East with graphene membrane filtration seawater desalination system solutions within the next three years. The new technology will be delivered and put into use at the latest in 2021.

The scale of demand of the major local tyrants is different, and the amount of contract orders is also different.

The Côte d'Azur signed the largest contract with Saat at $3.3 billion, followed by Qatar with $2.7 billion and the United Arab Emirates at $2.2 billion.

There are relatively few other local tyrants in the Middle East, but the entire group of local tyrants in the Middle East smashed 11.5 billion US dollars in one breath today.

Although it is impossible for Côte d’Azur Lab to recover the cost of graphene materials only by this order, this is only one of the application scenarios of graphene materials.

The most important thing is the continuous money-making effect. Graphene membrane filter materials are consumables, and this technology belongs to the Cote d'Azur, which means that the local tyrants will have to continue purchasing when they run out of it in the future.

Although it can't make a big profit at one time, the key point is to be able to maintain income during droughts and floods. As long as the "money ability" of the local tyrants does not disappear, you can earn this money steadily. How can the "money ability" of the local tyrants last for decades.

Earning for a few decades is not only enough, but also the rhythm of subsequent profits.

In fact, the contract list of more than 10 billion US dollars is an astronomical figure in itself, but it is a little less for the annual revenue of the Côte d'Azur.

But that is also a list of 11.5 billion US dollars, which can definitely be called a super large list.

The outside world knows that the deep ploughing of the Cote d'Azur over the past 15 years has finally come to fruition today, 15 years later.

It's time to harvest.

It is impossible to say that you are not envious, but you cannot be envious.

...

"The strong is always strong, the colossal size of the Cote d'Azur and the courage and foresight of the helmsman, the 'siphon effect' formed by it has almost extended his tentacles to all major boundaries in the field of science and technology. In the future... maybe we can only join This system can survive.”

A middle-aged man in a suit and leather shoes looked around the expo and couldn't help feeling emotional. His name was Ding Xian, and he was a manager of a venture capital institution.

There are too many people from investment institutions at the expo site, and almost all the technology companies participating in the exhibition are relatively potential startups, which are favored by venture capital institutions.

The reason is also very simple. These start-ups are basically companies invested by Côte d’Azur or Shengfeng Capital, or they are subsidiaries or affiliated companies, which means that these companies have been screened by Luo Sheng, the number one person in the global technology industry.

He is optimistic, and investors are of course more favored, which is equivalent to helping them pass a screening.

"Go look over there."

Ding Xian said something to the assistant secretary who followed him and walked towards the medical equipment exhibition area.

After a while, the two came to a very popular exhibition area. In addition to some technology enthusiasts and tourists, there were also many so-called elites in suits. They were basically either industry practitioners or VC people. This exhibition area It is a start-up company strategically invested by Côte d'Azur - Hongrui Medical.

The founders are Zhao Yu and Lu Zhengyang, both young doctors in their thirties. They both graduated from Rice University in North America and belonged to the same laboratory during their school days. Later, the two decided to return to China to start a business.

Originally, they didn't want to go back to China to start a business. The environment abroad is better, but one of the biggest factors that finally prompted them to go back to China to start a business was that there was a domestic tech giant named Luo Sheng, a tech company named Azure Coast, and a An investment institution called Shengfeng Capital.

Compared with other institutions or entrepreneurial environments, Luo Sheng and his subordinate institutions are really constantly investing in the field of technology, instead of making money, they are really constantly throwing money.

This gave the two of them great confidence. In fact, neither Cerulean Coast nor Shengfeng Capital failed their expectations. Zhao Yu personally found the people of Shengfeng Capital. As a result, halfway through his story, he took the same day. It has reached an angel round of investment of 4 million yuan.

Last year, Zhao Yu and Lu Zhengyang jointly published their latest nanomedicine research results in the journal Nature under the name of the Hongrui Medical Company they co-founded.

That is, a nanorobot that can kill cancer cells that they announced at the expo today.

At this moment, Ding Xian stood in the crowd silently watching Lu Zhengyang, who came here to promote his own products, introduce their achievements.

"The nanorobot developed by our company is only 1/50,000 of the diameter of a human hair. It can be driven by light, and it can drill into the protein-labeled protein in advance with a high-speed spin of 3 million times per second. Targeting the cancer cells, thereby tumbling inside the cancer cells. It only takes one to three minutes to physically kill the cancer cells completely."

Lu Zhengyang's introduction undoubtedly aroused the surprise of many people present, and most people showed surprised expressions when they heard him say this.

The so-called nano-robots are of course invisible to the naked eye. Lu Zhengyang also displayed it in his own exhibition area by playing videos in the laboratory, some microscopic display pictures, etc.

An industry insider present couldn't help but say: "As you said, even cancer cells that already have super drug resistance can't stand this toss, so what is the driving core of this nanorobot? "

Faced with inquiries from industry insiders, Lu Zhengyang explained with a smile: "The core structure that acts as the driving force of this nanorobot 'engine' is a rotor-like 'atomic chain' that we call a 'triple chain'. It is made of high-grade particles, which can move freely on the uneven atomic surface, relying on the 'drive shaft' of the 'triple chain' to complete."

The non-professional passers-by eating melons present can only feel a sense of ignorance.

Hongrui Medical was established in early 2015. This year, the concept of micro-molecular machines has not been popularized. It was not until 2016 that someone in this field won the Nobel Prize, and then it began to be popularized.

In 2014, Zhao Yu and Lu Zhengyang came up with the idea of ​​using the principles of molecular machines to develop nano-robots. It was precisely because of this opportunity that the two of them got to know each other, and their like-minded career made them decide to start a business together. Expect to use your professional knowledge and skills to make achievements in the field of micro-molecular machines.

This is the birth of Hongrui Medical.